Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia - Costs will probably vary according to local data

被引：0

|

作者：

Pugh, S

机构：

来源：

BRITISH MEDICAL JOURNAL | 1996年 / 313卷 / 7057期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：622 / 622

页数：1

相关论文

共 36 条

[31] Cost-effectiveness of a tailored Helicobacter pylori eradication strategy based on the presence of a 23S ribosomal RNA point mutation that causes clarithromycin resistance in Korean patients
Cho, Jun-Hyung
Jeon, Seong Ran
Kim, Hyun Gun
Jin, So-Young
Park, Suyeon
[J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (04) : 700 - 706
[32] Analysis of the prevalence of Helicobacter pylori infection and the effectiveness of eradication schemes in patients with the upper gastrointestinal tract disorders (according to the results of 13C-urea breath tests for 2006-2019)
Kondratiuk, Nataliia
Paliy, Iryna
Zaika, Serhii
[J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2021, 16 (03): : 229 - 234
[33] Cost-effectiveness of Helicobacter pylori near patient testing and endoscopy for initial management of dyspepsia in patients under 50 years of age:: Results of a primary care-based randomised controlled trial.
Delaney, BC
Wilson, S
Roalfe, A
Roberts, L
Redman, V
Hobbs, FDR
[J]. GUT, 2000, 46 : A86 - A86
[34] Cost-effectiveness of Helicobacter pylori point of care testing and endoscopy if positive for initial management of dyspepsia in patients under 50 years of age:: Results of a primary care-based randomised controlled trial.
Delaney, B
Wilson, S
Roalfe, A
Roberts, L
Redman, V
Hobbs, R
[J]. GASTROENTEROLOGY, 2000, 118 (04) : A441 - A441
[35] Effectiveness of 7-day and 14-day moxifloxacin-dexlansoprazole based triple therapy and probiotic supplement for Helicobacter pylori eradication in Thai patients with non-ulcer dyspepsia: A double-blind randomized placebo-controlled study
Chotivitayatarakorn, P.
Mahachai, V.
Vilaichone, R.
[J]. HELICOBACTER, 2017, 22
[36] EFFECTIVENESS OF 7-DAY AND 14-DAY MOXIFLOXACIN-DEXLANSOPRAZOLE BASED TRIPLE THERAPY AND PROBIOTIC SUPPLEMENT FOR HELICOBACTER PYLORI ERADICATION IN THAI PATIENTS WITH NON-ULCER DYSPEPSIA: A DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
Chotivitayatarakorn, Peranart
Siramolpiwat, Sith
Chonprasertsuk, Soonthorn
Kanokwanvimol, Amornnivit
Tangaroonsanti, Anupong
Bhanthumkomol, Patommatat
Pornthisarn, Bubpha
Mahachai, Varocha
Vilaichone, Ratha-Korn
[J]. GASTROENTEROLOGY, 2017, 152 (05) : S250 - S250

← 1 2 3 4 →